About Contact Us Careers

Osteoarthritis Therapeutics Market Analysis

Request Free Sample Copy

Report ID: 195
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Buy Now

Osteoarthritis Therapeutics Market Analysis

The osteoarthritis therapeutics market is segmented by distribution channel into hospital, retail, and online pharmacies. Out of which, the hospital sub-segment is anticipated to hold the largest share in the market during the forecast period on account of a large number of patients getting admitted to the hospitals. As hospitals are equipped with ultra-modern machines and talented doctors, plenty of patients are seeking treatment in the hospitals.

Our in-depth analysis of the global market includes the following segments:

Drug Class	Analgesics Nonsteroidal Anti-Inflammatory Drugs Corticosteroids Hyaluronic Acid Phase III Drugs
Route of Administration	Oral Parenteral
Diseases Type	Ankle Osteoarthritis Hip Osteoarthritis Knee Osteoarthritis Shoulder Osteoarthritis Others
Distribution Channel	Hospital Retail Online Pharmacies

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Osteoarthritis Therapeutics Market Size & Share, Growth Report 2037

Author Credits: Radhika Pawar

Report ID: 195
Published Date: Dec 23, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of osteoarthritis therapeutics is evaluated at USD 9.84 billion.

Osteoarthritis Therapeutics Market size was valued at USD 9.31 billion in 2024 and is set to exceed USD 21.63 billion by 2037, registering over 6.7% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to dominate majority revenue share by 2037, on the back of presence of ultra-modern healthcare infrastructure in the region.

The major players in the market are Bayer AG, Horizon Therapeutics plc, and Johnson & Johnson Services, Inc.

Inquiry Before Buying Request Free Sample